Citations 1268
Trial in Progress: REGN5458, a BCMAxCD3 Bispecific Antibody, in a Phase Ib Multi-Cohort Study of Combination Regimens for Patients with Relapsed/Refractory Multiple Myeloma
Kumar, Shaji , Leleu, Xavier , Manier, Salomon , Mateos, María‐Victoria , Bumma, Naresh , Gong, Weiying, Roy, Pourab, Lorenc, Karen Rodriguez , Kroog, Glenn S. , Sarkaria, Shawn , Rodríguez‐Otero, Paula , Joseph, Nisha S. , Lee, Hans C. , Dimopoulos, Meletios Α. , Oriol, Albert
Blood | November 29, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 4444-4446
Artificial Intelligence-Enhanced Models to Predict Light Chain Amyloidosis from Patients with Monoclonal Gammopathy of Undetermined Significance and Smoldering Multiple Myeloma
Dasari, Surendra , Grogan, Martha , Lacy, Martha Q. , Kourelis, Taxiarchis , Attia, Itzhak Z., Lopez‐Jimenez, Francisco, Murphree, Dennis H. , Friedman, Paul A. , Kumar, Shaji , Muchtar, Eli , Gertz, Morie A. , Buadi, Francis K. , Dingli, David , Attia, Itzhak Z., López-Jiménez, Francisco , Dispenzieri, Angela
Blood | November 29, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 7230-7232
Fixed Duration Therapy with Daratumumab, Carfilzomib, Lenalidomide and Dexamethasone for High Risk Smoldering Multiple Myeloma-Results of the Ascent Trial
Kumar, Shaji , Alsina, Melissa , LaPlant, Betsy, Badros, Ashraf , Abonour, Rafat , Asmus, Erik, Dhakal, Binod , Rosenbaum, Cara A. , Egan, Daniel , Bhutani, Manisha , Durie, Brian G.M. , Abdallah, Al-Ola , Dhakal, Binod , Jakubowiak, Andrzej
Blood | November 29, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 1830-1832
Validation of a Novel Rac1 Inhibitor As Potent Secdrug Against Activating Ras Mutant and Drug-Resistant Multiple Myeloma
Ahmed, Salsabil, Wiesen, Lisa, Sharma, Neeraj , Mukherjee, Ujjal Kumar , Kumar, Shaji , Ness, Brian G. Van , Sharma, Neeraj , Mazumder, Suman , Baughn, Linda B. , Mitra, Amit
Blood | November 29, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 4249-4250
AI-Enabled Screening for Drug Repurposing in Monoclonal Gammopathy of Undetermined Significance
Ryu, Alexander J. , Kumar, Shaji , Kyle, Robert A. , Kingsley, Thomas C. , Ryu, Alexander J. , Dispenzieri, Angela , Rajkumar, S. Vincent
Blood | November 29, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 7842-7843
Single-Cell Dissection of Primary Quadruplet- and Triplet-Resistant Multiple Myeloma
Ismail, Wazim Mohammed , Maia, Alexandre Gaspar, Kumar, Shaji , Mohammed Ismail, Wazim , Binder, Moritz , Mazzone, Amelia , Fernandez, Jenna , Rajkumar, S. Vincent
Blood | November 29, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 9978-9979
A Phase 1 First-in-Human Study of Abbv-383, a BCMA × CD3 Bispecific T-Cell-Redirecting Antibody, As Monotherapy in Patients with Relapsed/Refractory Multiple Myeloma
Voorhees, Peter M. , Hurd, David D., Rodriguez, Cesar , Korde, Neha , Safah, Hana, Bueno, Orlando F. , Pumford, Neil R., Rosenberg, Tanya S, Pothacamury, Rajvineeth Kumar, Polepally, Akshanth R. , Talati, Chetasi, Vij, Ravi , Kumar, Shaji , D’Souza, Anita , Weisel, Katja C , Teipel, Raphael , Chung, Alfred , Tuchman, Sascha Alexander , Pumford, Neil, Ross, Jeremy A. , Lee, Shane , Jin, Ziyi , Talati, Chetasi
Blood | November 29, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 4401-4404
Persistance or Reappearance of Serum Monoclonal Protein Detected By Mass Spectrometry Is a Major Prognostic Factor in Patients with Newly Diagnosed Multiple Myeloma
Murray, David , Kapoor, Prashant , Fonder, Amie , Hayman, Suzanne R. , Hobbs, Miriam, Hwa, Yi L., Kourelis, Taxiarchis , Lacy, Martha Q. , Lin, Yi , Warsame, Rahma , Kyle, Robert A. , Kumar, Shaji , Claveau, Jean‐Sébastien , Dispenzieri, Angela , Binder, Moritz , Buadi, Francis K. , Dingli, David , Gertz, Morie A. , Gonsalves, Wilson I. , Leung, Nelson , Rajkumar, S. Vincent
Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 2347-2348
Daratumumab Plus Lenalidomide and Dexamethasone (D-Rd) Versus Lenalidomide and Dexamethasone (Rd) in Transplant-Ineligible Patients (Pts) with Newly Diagnosed Multiple Myeloma (NDMM): Clinical Assessment of Key Subgroups of the Phase 3 Maia Study
Usmani, Saad Z. , Plesner, Torben , Hulin, Cyrille , Goldschmidt, Hartmut , Venner, Christopher P. , Tiab, Mourad, Macro, Margaret , Leleu, Xavier , Pei, Huiling , Krevvata, Maria, Carson, Robin, Borgsten, Fredrik, Kumar, Shaji , Usmani, Saad , Moreau, Philippe , Facon, Thierry T.F. , Bahlis, Nizar Jacques , Raje, Noopur , Orlowski, Robert Z. , Basu, Supratik , Nahi, Hareth , Quach, Hang , O’Dwyer, Michael , Perrot, Aurore , Weisel, Katja C , Frenzel, Laurent
Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 7297-7300
Results from the First Phase 1 Clinical Study of the B-Cell Maturation Antigen (BCMA) Nex T Chimeric Antigen Receptor (CAR) T Cell Therapy CC-98633/BMS-986354 in Patients (pts) with Relapsed/Refractory Multiple Myeloma (RRMM)
Kumar, Shaji , Liedtke, Michaela , Mailankody, Sham , Limones, Josiana, Das, Sharmila , Thorpe, Jerill , Cacciatore, Jonathan J. , Navarro, Garnet, Koegel, Ashley K., Burgess, Michael R., Hege, Kristen , Costa, Luciano J. , Atrash, Shebli , Kaur, Gurbakhash , Derman, Benjamin A. , Bergsagel, P. Leif , McCarthy, Philip L. , Chen, Yanping , Richard, Shambavi
Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 1360-1362